These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22987264)

  • 21. In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii.
    Liu B; Bai Y; Liu Y; Di X; Zhang X; Wang R; Wang J
    J Chemother; 2015 Oct; 27(5):271-6. PubMed ID: 25068186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unexpected tigecycline resistance among Acinetobacter baumannii Isolates: high minor error rate by Etest.
    Kulah C; Celebi G; Aktas E; Mengeloglu Z; Comert F; Ankarali H
    J Chemother; 2009 Aug; 21(4):390-5. PubMed ID: 19622456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Over expression of AdeABC and AcrAB-TolC efflux systems confers tigecycline resistance in clinical isolates of Acinetobacter baumannii and Klebsiella pneumoniae.
    Yuhan Y; Ziyun Y; Yongbo Z; Fuqiang L; Qinghua Z
    Rev Soc Bras Med Trop; 2016 Apr; 49(2):165-71. PubMed ID: 27192584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro tigecycline and carbapenem susceptibilities of clinical Acinetobacter baumannii isolates].
    Nayman Alpat S; Aybey AD; Akşit F; Ozgüneş I; Kiremitçi A; Usluer G
    Mikrobiyol Bul; 2010 Oct; 44(4):641-5. PubMed ID: 21063976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro activity of tigecycline against multiple resistant Acinetobacter baumannii and carbapenem resistant Klebsiella pneumoniae isolates].
    Arikan Akan O; Uysal S
    Mikrobiyol Bul; 2008 Apr; 42(2):209-15. PubMed ID: 18697418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline.
    Somily AM; Absar MM; Arshad MZ; Al Aska AI; Shakoor ZA; Fatani AJ; Siddiqui YM; Murray TS
    Saudi Med J; 2012 Jul; 33(7):750-5. PubMed ID: 22821309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of manganese in test media on in vitro susceptibility of Enterobacteriaceae and Acinetobacter baumannii to tigecycline.
    Veenemans J; Mouton JW; Kluytmans JA; Donnely R; Verhulst C; van Keulen PH
    J Clin Microbiol; 2012 Sep; 50(9):3077-9. PubMed ID: 22718943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp.
    Casal M; Rodríguez F; Johnson B; Garduno E; Tubau F; de Lejarazu RO; Tenorio A; Giménez MJ; Bartolomé R; Garcia-Rey C; Aguilar L; García-Escribano N
    J Antimicrob Chemother; 2009 Jul; 64(1):69-72. PubMed ID: 19451133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009.
    Morfin-Otero R; Dowzicky MJ
    Clin Ther; 2012 Jan; 34(1):101-12. PubMed ID: 22177546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii.
    Capone A; D'Arezzo S; Visca P; Petrosillo N;
    J Antimicrob Chemother; 2008 Aug; 62(2):422-3. PubMed ID: 18424790
    [No Abstract]   [Full Text] [Related]  

  • 31. Rapid development of Acinetobacter baumannii resistance to tigecycline.
    Reid GE; Grim SA; Aldeza CA; Janda WM; Clark NM
    Pharmacotherapy; 2007 Aug; 27(8):1198-201. PubMed ID: 17655518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergy testing of multidrug resistant Acinetobacter baumanii against tigecycline and polymyxin using an E-test methodology.
    Sands M; McCarter Y; Sanchez W
    Eur J Clin Microbiol Infect Dis; 2007 Jul; 26(7):521-2. PubMed ID: 17558487
    [No Abstract]   [Full Text] [Related]  

  • 34. [Activity of tigecycline on planktonic and sessile cells of Acinetobacter baumannii].
    Can F; Kaya M; Bayindir Bilman F; Uncu H; Demirbilek M; Yazici AC
    Mikrobiyol Bul; 2009 Oct; 43(4):587-95. PubMed ID: 20084911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Resistance of
    Qu JY; Ü XJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):248-252. PubMed ID: 28612536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii.
    Dong X; Chen F; Zhang Y; Liu H; Liu Y; Ma L
    J Antibiot (Tokyo); 2014 Sep; 67(9):677-80. PubMed ID: 25095805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
    Dowzicky MJ; Park CH
    Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative evaluation of minocycline susceptibility testing methods in carbapenem-resistant Acinetobacter baumannii.
    Dimitriadis P; Protonotariou E; Varlamis S; Poulou A; Vasilaki O; Metallidis S; Tsakris A; Malisiovas N; Skoura L; Pournaras S
    Int J Antimicrob Agents; 2016 Sep; 48(3):321-3. PubMed ID: 27451087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the Accelerate Pheno System for Identification of
    Bowler SL; Towne JW; Humphries RM; Doi Y
    J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30651391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of insertion sequence Aba-1 and AdeS in reduced tigecycline susceptibility in MDR-Acinetobacter baumannii clinical isolates from Cairo, Egypt.
    Hassan R; Mukhtar A; Hasanin A; Ghaith D
    J Chemother; 2018 Apr; 30(2):89-94. PubMed ID: 29108486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.